May 28, 2019 ProMIS Neurosciences Identifies Novel Antibodies for Alzheimer's Disease with Selectivity for the Neurotoxic Form of Tau
Mar 21, 2019 Aducanumab Failure: Selectivity for the Toxic Oligomer is Essential to Treating Root Cause of Alzheimer's Disease
Mar 19, 2019 ProMIS Neurosciences to Present Data for Potential Best-in-Class Antibody Candidates for Parkinson's Disease at AD/PD™ 2019 Conference
Jan 31, 2019 Selectivity for the Toxic Oligomer Essential to Treating Root Cause of Alzheimer's Disease